← Back to Clinical Trials
Recruiting NCT06577870

NCT06577870 Immersive Sensory Projections for Hospitalized Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06577870
Status Recruiting
Phase
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition Hospitalism
Study Type INTERVENTIONAL
Enrollment 208 participants
Start Date 2025-05-20
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Hospitalization in intensive care or continuing care unit

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 208 participants in total. It began in 2025-05-20 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit/continuing care unit.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years ; * Patient hospitalized in intensive care or continuing care unit for an estimated minimum of 48 hours; * Patient hospitalized for a medical indication (including in the pre-surgical phase) or in the post-surgical phase; * Patient or support person who speaks and understands French, has understood the research procedures and is able to complete the questionnaires; * For women of childbearing age (non-menopausal), even for those on contraception: negative pregnancy test (urinary); If positive: completed by a biological test; * Patient or trusted support person having been informed and having signed an informed consent form to participate in the study. Exclusion Criteria: * Deaf or blind patient; * Asthmatic patient with background treatment; * Epileptic patient or known history of convulsion; * Known allergy or intolerance to essential oils or to a component of essential oils; * Patient transferred from another intensive care unit; * Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision); * Breast-feeding or pregnant women; * Patient or support person unable to understand information relating to the study (linguistic, psychological, cognitive, etc.); * Unconscious patient with no relative or support person present; * Homeless patient; * Patient with known severe psychiatric illness such as chronic hallucinatory psychosis or paranoid syndrome; * Patient participating in or being excluded from another clinical trial; * Patient not covered by a social security scheme.

Contact & Investigator

Central Contact

Igor LACOMBAT, MD

✉ igor.lacombat@gmail.com

📞 660406554

Frequently Asked Questions

Who can join the NCT06577870 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hospitalism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06577870 currently recruiting?

Yes, NCT06577870 is actively recruiting participants. Contact the research team at igor.lacombat@gmail.com for enrollment information.

Where is the NCT06577870 trial being conducted?

This trial is being conducted at Massy, France.

Who is sponsoring the NCT06577870 clinical trial?

NCT06577870 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 208 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology